Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep;39(9):2027-2033.
doi: 10.1007/s10815-022-02588-9. Epub 2022 Aug 17.

Preimplantation genetic testing for aneuploidy in patients with low embryo numbers: benefit or harm?

Affiliations

Preimplantation genetic testing for aneuploidy in patients with low embryo numbers: benefit or harm?

Arnold M Mahesan et al. J Assist Reprod Genet. 2022 Sep.

Erratum in

Abstract

Purpose: We sought to explore the utility of preimplantation genetic testing for aneuploidy (PGT-A) in a poor prognosis group of women with few embryos available for transfer.

Methods: This was a retrospective matched cohort study examining records for first or second-cycle IVF patients with 1 to 3 blastocysts. The study group comprised 130 patients who underwent PGT-A on all embryos. The control group included 130 patients matched by age, BMI, and blastocyst number and quality who did not undergo PGT-A during the same time period.

Results: The live birth rate (LBR) per embryo transfer (ET) were similar in the PGT-A and control groups, and the spontaneous abortion (SAB) rate was the same (23%). However, we found a significantly higher LBR per oocyte retrieval in the control group vs the PGT-A group (43% vs 20%, respectively) likely due to the many no-euploid cycles in the PGT-A group. In a subgroup analysis for age, the similar LBR per ET persisted in women < 38. However, in older women, there was a trend to a higher LBR per ET in the PGT-A group (43%) vs the control group (22%) but a higher LBR per oocyte retrieval in the control group (31%) vs the PGT-A group (13%).

Conclusions: Overall, we observed a significant increase in LBR per oocyte retrieval in women in the control group compared to women undergoing PGT-A, and no difference in SAB rate. Our data suggests that PGT-A has no benefit in a subpopulation of women with few embryos and may cause harm.

Keywords: In vitro fertilization; Low ovarian reserve; Pregnancy; Preimplantation genetic testing.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
The treatment pathways including live birth outcome for the 130 cycles yielding 1 to 3 blastocysts where PGT-A was performed (top) and the 130 matched control cycles that did not undergo PGT-A (bottom)
Fig. 2
Fig. 2
The increase in cumulative birth per oocyte retrieval with each successive embryo transfer in the PGT-A group vs the control group
Fig. 3
Fig. 3
Live birth per embryo transfer and per oocyte retrieval for women < 38 and women 38 + in the PGT-A group vs the control group
Fig. 4
Fig. 4
Cumulative live birth per oocyte retrieval for women with 1, 2, and 3 blastocysts in the PGT-A group vs the control groups

References

    1. Gleicher N, Orvieto R. "Is the hypothesis of preimplantation genetic screening (PGS) still supportable? A review," (in eng) J Ovarian Res. 2017;10(1):21. doi: 10.1186/s13048-017-0318-3. - DOI - PMC - PubMed
    1. Gleicher N, Patrizio P, Orvieto R. "How not to introduce laboratory tests to clinical practice: preimplantation genetic testing for aneuploidy," (in eng) Clin Chem. 2022;68(4):501–503. doi: 10.1093/clinchem/hvac001. - DOI - PubMed
    1. Yang M, et al. "Author Correction: Depletion of aneuploid cells in human embryos and gastruloids," (in eng) Nat Cell Biol. 2021;23(11):1212. doi: 10.1038/s41556-021-00775-x. - DOI - PubMed
    1. Bolton H, et al. "Mouse model of chromosome mosaicism reveals lineage-specific depletion of aneuploid cells and normal developmental potential," (in eng) Nat Commun. 2016;7:11165. doi: 10.1038/ncomms11165. - DOI - PMC - PubMed
    1. Kang HJ, Melnick AP, Stewart JD, Xu K, Rosenwaks Z. "Preimplantation genetic screening: who benefits?," (in eng) Fertil Steril. 2016;106(3):597–602. doi: 10.1016/j.fertnstert.2016.04.027. - DOI - PubMed